HHC – Is It A Stroke? The Latest Theories, Therapies and Medications

About this Video

Dr. Kent’s own research spans from the basic science of oxidative stress in the nervous system, clinical trials of novel intravenous drug combinations for acute ischemic stroke, and development of outcome methodologies. He has a special interest in diabetes and hyperglycemia, the mechanisms by which they influence stroke outcomes and their role in the poor outcomes seen especially in minority populations.

 

Speaker – Dr. Thomas Kent, Chief of Neurology, Michael E. DeBakey Veterans Affairs Medical Center, and Director of Stroke Research and Education, Baylor College of Medicine

Print Friendly